We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+24.16%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$375B
AUM Growth
+$72.8B
Cap. Flow
+$9.25B
Cap. Flow %
2.47%
Top 10 Hldgs %
20.56%
Holding
4,266
New
170
Increased
1,923
Reduced
1,788
Closed
190

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$478M
2
RTN
Raytheon Company
RTN
+$318M
3
MRK icon
Merck
MRK
+$257M
4
JNJ icon
Johnson & Johnson
JNJ
+$251M
5
QCOM icon
Qualcomm
QCOM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Healthcare 14.18%
3 Financials 11.46%
4 Consumer Discretionary 10.84%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVR icon
2076
Invesco Mortgage Capital
IVR
$805M
$6.5M ﹤0.01%
173,859
-16,704
-9% -$574K
RPT
2077
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$6.48M ﹤0.01%
931,387
-296,025
-24% -$1.89M
PRNB
2078
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$6.47M ﹤0.01%
108,266
+15,344
+17% +$948K
IBB icon
2079
iShares Biotechnology ETF
IBB
$9.73B
$6.46M ﹤0.01%
47,272
+11,594
+32% +$1.48M
ESRT icon
2080
Empire State Realty Trust
ESRT
$822M
$6.43M ﹤0.01%
919,316
-2,679,381
-74% -$20.7M
ALTR
2081
DELISTED
Altair Engineering Inc
ALTR
$6.43M ﹤0.01%
161,861
+5,302
+3% +$180K
ITCI
2082
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.42M ﹤0.01%
250,170
+18,143
+8% +$367K
ZUMZ icon
2083
Zumiez
ZUMZ
$314M
$6.42M ﹤0.01%
234,359
-1,356
-0.6% -$30.8K
VGT icon
2084
Vanguard Information Technology ETF
VGT
$150B
$6.41M ﹤0.01%
183,888
+296
+0.2% +$9.24K
XLF icon
2085
State Street Financial Select Sector SPDR ETF
XLF
$59.4B
$6.39M ﹤0.01%
276,209
+84,276
+44% +$1.91M
VREX icon
2086
Varex Imaging
VREX
$779M
$6.39M ﹤0.01%
421,609
-22,578
-5% -$456K
SRDX
2087
DELISTED
Surmodics
SRDX
$6.38M ﹤0.01%
147,663
+1,246
+0.9% +$47.2K
CLW icon
2088
Clearwater Paper
CLW
$345M
$6.37M ﹤0.01%
176,317
-5,736
-3% -$160K
SSP icon
2089
E.W. Scripps
SSP
$320M
$6.36M ﹤0.01%
726,683
-12,048
-2% -$96.6K
MRSN
2090
DELISTED
Mersana Therapeutics
MRSN
$6.35M ﹤0.01%
10,854
+3,053
+39% +$1.04M
MCHB
2091
Mechanics Bancorp
MCHB
$3.78B
$6.34M ﹤0.01%
257,702
-12,143
-4% -$282K
PUMP icon
2092
ProPetro Holding
PUMP
$1.49B
$6.31M ﹤0.01%
1,228,114
-35,255
-3% -$162K
NXGN
2093
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$6.31M ﹤0.01%
574,599
+19,812
+4% +$205K
UTL icon
2094
Unitil
UTL
$995M
$6.31M ﹤0.01%
140,726
-1,368
-1% -$66.9K
PLOW icon
2095
Douglas Dynamics
PLOW
$976M
$6.3M ﹤0.01%
179,327
-3,620
-2% -$126K
ACH
2096
Accendra Health
ACH
$73.1M
$6.28M ﹤0.01%
824,205
-15,471
-2% -$113K
BANF icon
2097
BancFirst
BANF
$3.89B
$6.28M ﹤0.01%
154,719
-5,576
-3% -$205K
ICHR icon
2098
Ichor Holdings
ICHR
$2.66B
$6.27M ﹤0.01%
235,890
-4,066
-2% -$92.8K
DCOM
2099
DELISTED
Dime Community Bancshares
DCOM
$6.27M ﹤0.01%
456,526
-1,212
-0.3% -$17.6K
LMAT icon
2100
LeMaitre Vascular
LMAT
$1.88B
$6.26M ﹤0.01%
237,281
+5,369
+2% +$140K

Similar funds

Bank of New York Mellon's Q2 2020 Portfolio in Review

As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
  • Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
  • Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
  • Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
  • Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
  • Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
  • Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.

Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.